Ask AI
TD in Mood Disorders

CE / CME

Managing Tardive Dyskinesia in Mood Disorders: Evidence-Based Approaches for Patients on Antipsychotic Therapy

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Pharmacists: 1.00 contact hour (0.1 CEUs)

Nurse Practitioners/Nurses: 1.00 Nursing contact hour

Psychologists: 1.00 APA CE Credit

Social Workers: 1.00 ASWB ACE CE Credit

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Released: September 25, 2025

Expiration: September 24, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

Among the following risk factors for developing TD, which is of particular relevance in older patients?

2.

When assessing a patient’s movement, which symptom would indicate a diagnosis OTHER THAN TD?

3.

Which statement is true as supported by published data on VMAT2 inhibitors specific to older adults with TD?

4.

Evelyn is a 70-yr-old woman with bipolar I disorder who has been stable for several yr on olanzapine 10 mg nightly and lithium 900 mg/day (serum level 0.8 mEq/L). She also has osteoarthritis of her knees and a history of hepatitis C–related cirrhosis. Her liver disease is currently Child-Pugh class B (moderate impairment), with stable labs and no history of encephalopathy.


Evelyn retired from her job as a high school English teacher but continues to work part-time at a local library leading a children’s reading program. She enjoys the work but says the involuntary lip-smacking and tongue movements have become increasingly noticeable, and some parents have asked if she is “okay.” She has also started avoiding social gatherings at church.


Her HCP diagnosed tardive dyskinesia 1 yr ago. A prior attempt to taper olanzapine led to recurrence of mania with reduced sleep and pressured speech. Evelyn is now psychiatrically stable, but the TD symptoms are distressing and interfere with her quality of life.

What is the next best course of action?